AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25516991 — intervention group
Group type: COMPARATOR
Intervention: Control group in experienced group
Number of subjects: 0
Study 25516991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice application
Number of subjects: 0
Study 25516991 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 23791399 — intervention group
Group type: EXPERIMENTAL
Intervention: EnSeal device
Number of subjects: 160
Study 23791399 — intervention group
Group type: COMPARATOR
Intervention: Standard bipolar coagulation forceps
Number of subjects: 160
Study 22419265 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed weight-bearing device
Number of subjects: 300
Study 22419265 — intervention group
Group type: COMPARATOR
Intervention: Mobile weight-bearing device
Number of subjects: 300
Study 19542476 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month treatment arm
Number of subjects: 370
Study 19542476 — intervention group
Group type: COMPARATOR
Intervention: 6-month treatment arm
Number of subjects: 370
Study 17697456 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone acetate 1% formulation A
Number of subjects: 0
Study 17697456 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1% formulation B
Number of subjects: 0
Study 16829672 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium (R)
Number of subjects: 25
Study 16829672 — intervention group
Group type: COMPARATOR
Intervention: Saline (S)
Number of subjects: 25
Study 16829672 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recordings
Number of subjects: 25
Study 16829672 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 25
Study 16829672 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of eyelash reflex (LER)
Number of subjects: 25
Study 16829672 — intervention group
Group type: EXPERIMENTAL
Intervention: Steady state (SS) for all patients
Number of subjects: 25
Study 16829672 — intervention group
Group type: COMPARATOR
Intervention: Steady state (SS) for Group S
Number of subjects: 25
Study 16829672 — intervention group
Group type: EXPERIMENTAL
Intervention: Steady state (SS) for Group R
Number of subjects: 25
Study 14632962 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline 150 mg/day
Number of subjects: 48
Study 14632962 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine 60 mg/day
Number of subjects: 48
Study 10928310 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (4, 8, 16 mg)
Number of subjects: 7
Study 10928310 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine/naloxone (1/0.25, 2/0.5, 4/1, 8/2, 16/4 mg)
Number of subjects: 7
Study 10928310 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular hydromorphone (2, 4 mg)
Number of subjects: 7
Study 10928310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 8872617 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticoid therapy (2 x 100 micrograms beclomethasone 4 times/day for 2.5 yr)
Number of subjects: 15
Study 8872617 — intervention group
Group type: COMPARATOR
Intervention: No inhaled glucocorticoid therapy
Number of subjects: 15
Study 8872617 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthmatic smokers
Number of subjects: 15
Study 8872617 — intervention group
Group type: COMPARATOR
Intervention: Asthmatic nonsmokers
Number of subjects: 15
Study 1531234 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐0 nylon suture
Number of subjects: 200
Study 1531234 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐0 polypropylene (Prolene) suture
Number of subjects: 200
Study 1531234 — intervention group
Group type: EXPERIMENTAL
Intervention: 11‐0 polyester (Mersilene) suture
Number of subjects: 200
Study 1531234 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐0 polyethylene (Novafil) suture
Number of subjects: 200
Study 6471383 — intervention group
Group type: EXPERIMENTAL
Intervention: CET 30 mg/kg
Number of subjects: 18
Study 6471383 — intervention group
Group type: EXPERIMENTAL
Intervention: LMOX 30 mg/kg
Number of subjects: 18
Study 6471383 — intervention group
Group type: EXPERIMENTAL
Intervention: LMOX 20 mg/kg
Number of subjects: 18
Study 31855244 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet function testing guided de-escalation of DAPT
Number of subjects: 2610
Study 31855244 — intervention group
Group type: COMPARATOR
Intervention: Control group with prasugrel for 12 months
Number of subjects: 2610
Study 31855244 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring group with guided de-escalation of DAPT
Number of subjects: 2610
Study 31855207 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative compression using an elastic stocking
Number of subjects: 40
Study 31855207 — intervention group
Group type: COMPARATOR
Intervention: Elastic bandaging
Number of subjects: 40
Study 29125592 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone (Radicava)
Number of subjects: 0
Study 29125592 — intervention group
Group type: COMPARATOR
Intervention: Riluzole (Rilutek, and generics)
Number of subjects: 0
Study 26303787 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity treadmill training (HI-TM, 80% HRR)
Number of subjects: 34
Study 26303787 — intervention group
Group type: COMPARATOR
Intervention: Lower intensity treadmill training (LO-TM, 50% HRR)
Number of subjects: 34
Study 22903545 — intervention group
Group type: EXPERIMENTAL
Intervention: CpG stimulation of B cells in vitro and in vivo
Number of subjects: 0
Study 22903545 — intervention group
Group type: EXPERIMENTAL
Intervention: BTLA ligation with HVEM
Number of subjects: 0
Study 22903545 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocking BTLA/HVEM interactions
Number of subjects: 0
Study 22903545 — intervention group
Group type: EXPERIMENTAL
Intervention: BTLA/HVEM ligation
Number of subjects: 0
Study 21850488 — intervention group
Group type: EXPERIMENTAL
Intervention: Philani Plus (+) intervention (n=645 MAR) with four antenatal and four postnatal home visits by trained Mentor Mother CHWs.
Number of subjects: 1239
Study 21850488 — intervention group
Group type: COMPARATOR
Intervention: Standard-care control condition (n=594 MAR) of neighborhood clinic-based services.
Number of subjects: 1239
Study 19398163 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 0
Study 19398163 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief and extended interventions (CBT)
Number of subjects: 0
Study 16506060 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treadmill running at 80% VO2max to volitional exhaustion
Number of subjects: 0
Study 16506060 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate treadmill running at 60% VO2max
Number of subjects: 0
Study 16506060 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill treadmill running at -10% at 80% VO2max
Number of subjects: 0
Study 16506060 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intensive and eccentric protocols
Number of subjects: 0
Study 14746625 — intervention group
Group type: EXPERIMENTAL
Intervention: Griseofulvin 500 mg twice daily for 4 weeks
Number of subjects: 59
Study 14746625 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg daily for 4 weeks
Number of subjects: 59
Study 14746625 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 200 mg once weekly for 4 weeks
Number of subjects: 59
Study 14746625 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole 200 mg twice daily for 1 week
Number of subjects: 59
Study 11758945 — intervention group
Group type: EXPERIMENTAL
Intervention: I-123 MIBG pulmonary accumulation and washout
Number of subjects: 19
Study 11758945 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers (NL)
Number of subjects: 19
Study 8986530 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO classification of 1975
Number of subjects: 128
Study 8986530 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO classification of 1994
Number of subjects: 128
Study 8986530 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO classification of 1975 (reduced to two categories)
Number of subjects: 128
Study 8986530 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO classification of 1994 (reduced to two categories)
Number of subjects: 128
Study 8986530 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO classification of 1975 (intraobserver)
Number of subjects: 128
Study 8986530 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO classification of 1994 (intraobserver)
Number of subjects: 128
Study 8487051 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant fluorouracil (FUra) infusional therapy (1.2 g/m2 per 24 hours)
Number of subjects: 0
Study 8487051 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0
Study 3525302 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intervention including diet, cholesterol drugs, anti-hypertensive drugs, anti-smoking advice, and increased physical activity for 6 years
Number of subjects: 6027
Study 3525302 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated group
Number of subjects: 6027
Study 3525302 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6027
Study 30843995 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular Protection
Number of subjects: 80
Study 30843995 — intervention group
Group type: COMPARATOR
Intervention: Non‐Protection
Number of subjects: 80
Study 28130176 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT)
Number of subjects: 22
Study 28130176 — intervention group
Group type: COMPARATOR
Intervention: N/A (comparison between groups)
Number of subjects: 22
Study 25464425 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training program (10 weeks)
Number of subjects: 40
Study 25464425 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular sports or exercise participation at baseline
Number of subjects: 40
Study 25464425 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports participation
Number of subjects: 40
Study 22469637 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal (MM) assessment
Number of subjects: 182
Study 22469637 — intervention group
Group type: COMPARATOR
Intervention: Routine multidisciplinary assessment (Control)
Number of subjects: 182
Study 21156659 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy (angiography with intent to revascularization)
Number of subjects: 138
Study 21156659 — intervention group
Group type: COMPARATOR
Intervention: Conservative management strategy
Number of subjects: 138
Study 19023649 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose followed by daily 75 mg maintenance dose for 28 days
Number of subjects: 0
Study 19023649 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg loading dose followed by daily 10 mg maintenance dose for 28 days
Number of subjects: 0
Study 19023649 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study 19023649 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 0
Study 17067774 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoring method treating late responses as incorrect
Number of subjects: 96
Study 17067774 — intervention group
Group type: COMPARATOR
Intervention: Scoring method treating late responses as correct
Number of subjects: 96
Study 12957561 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese subjects
Number of subjects: 50
Study 12957561 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 50
Study 12807410 — intervention group
Group type: EXPERIMENTAL
Intervention: Rightward-moving sounds with falling pitch and leftward-moving sounds with rising pitch (induction phase)
Number of subjects: 0
Study 12807410 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual stimulus moving in the opposite direction of the sound
Number of subjects: 0
Study 12807410 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual motion combined with a stationary sound
Number of subjects: 0
Study 11057797 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO)
Number of subjects: 25
Study 11057797 — intervention group
Group type: COMPARATOR
Intervention: Standard care (for nonresponders)
Number of subjects: 25
Study 11057797 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 25
Study 8646867 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate ointment, 0.005%
Number of subjects: 92
Study 8646867 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone-17,21-dipropionate ointment, 0.05%
Number of subjects: 92
Study 2049246 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg
Number of subjects: 12
Study 2049246 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg
Number of subjects: 12
Study 2049246 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 12
Study 2049246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6380348 — intervention group
Group type: EXPERIMENTAL
Intervention: Trental 400
Number of subjects: 36
Study 6380348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 31178433 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine followed by metformin
Number of subjects: 223
Study 31178433 — intervention group
Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 223
Study 29924461 — intervention group
Group type: EXPERIMENTAL
Intervention: Active counterpulsation
Number of subjects: 28
Study 29924461 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 28
Study 27295871 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannous-containing sodium fluoride dentifrice, advanced manual toothbrush, and CPC rinse
Number of subjects: 35
Study 27295871 — intervention group
Group type: COMPARATOR
Intervention: Negative control regimen (0.243% sodium fluoride dentifrice and soft flat trim manual toothbrush)
Number of subjects: 35
Study 24953766 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate 15-20 mg/kg + 300 mg allopurinol twice a day
Number of subjects: 57
Study 24953766 — intervention group
Group type: COMPARATOR
Intervention: Sodium valproate 15-20 mg/kg + placebo
Number of subjects: 57
Study 23161092 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised feedback alone
Number of subjects: 0
Study 23161092 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised feedback in combination with peer support
Number of subjects: 0
Study 23161092 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 20600551 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan treatment at concentrations of 2.5mg/mL and 5.0mg/mL for 60s to 90s
Number of subjects: 0
Study 20600551 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan treatment
Number of subjects: 0
Study 17903231 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐day course at local hospital
Number of subjects: 140
Study 17903231 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐day course at simulation centre
Number of subjects: 140
Study 17903231 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐day course with teamwork training at local hospital
Number of subjects: 140
Study 17903231 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐day course with teamwork training at simulation centre
Number of subjects: 140
Study 17903231 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 140
Study 16282843 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone supplementation
Number of subjects: 26
Study 16282843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 12121395 — intervention group
Group type: EXPERIMENTAL
Intervention: Desonide 0.05% lotion
Number of subjects: 81
Study 12121395 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 81
Study 10789216 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy diet
Number of subjects: 86
Study 8815553 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 283
Study 8815553 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 283
Study 8815553 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 283
Study 2195084 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of intrinsic motivation
Number of subjects: 1368
Study 2195084 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of extrinsic motivation
Number of subjects: 1368
Study 518220 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (100 mg/day)
Number of subjects: 29
Study 518220 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (400 mg/day)
Number of subjects: 29
Study 31993664 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled e‐cigarette device with flavored or unflavored e‐liquids
Number of subjects: 49
Study 31993664 — intervention group
Group type: EXPERIMENTAL
Intervention: Assigned e‐liquid flavor
Number of subjects: 49
Study 31395295 — intervention group
Group type: EXPERIMENTAL
Intervention: LBBB
Number of subjects: 22067
Study 31395295 — intervention group
Group type: EXPERIMENTAL
Intervention: L-IVCD
Number of subjects: 22067
Study 31395295 — intervention group
Group type: EXPERIMENTAL
Intervention: LVCD (LBBB or L-IVCD)
Number of subjects: 22067
Study 25168967 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 80
Study 25168967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 23273697 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative IMA embolization
Number of subjects: 266
Study 23273697 — intervention group
Group type: COMPARATOR
Intervention: Control group (no embolization)
Number of subjects: 266
Study 21470283 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH (0.067 mg/kg per day) as daily subcutaneous injections
Number of subjects: 22
Study 21470283 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rhGH)
Number of subjects: 22
Study 21470283 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH group
Number of subjects: 22
Study 21470283 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 17658525 — intervention group
Group type: EXPERIMENTAL
Intervention: 17alpha-hydroxyprogesterone caproate (17-HPC) 250 mg, i.m., 1 day before ET
Number of subjects: 125
Study 17658525 — intervention group
Group type: COMPARATOR
Intervention: Control group (no injections)
Number of subjects: 125
Study 16846869 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-closure of peritoneum
Number of subjects: 54
Study 16846869 — intervention group
Group type: COMPARATOR
Intervention: Closure of peritoneum
Number of subjects: 54
Study 14503057 — intervention group
Group type: EXPERIMENTAL
Intervention: Qinwen Baidu Decoction (QBD)
Number of subjects: 46
Study 14503057 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (Control)
Number of subjects: 46
Study 11155154 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose IFNalpha-2b (3 MU) three times weekly for 3 months (Group 2)
Number of subjects: 53
Study 11155154 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose IFNalpha-2b (6-10 MU) three times weekly for 3 months (Group 3)
Number of subjects: 53
Study 11155154 — intervention group
Group type: COMPARATOR
Intervention: No specific treatment (Control Group 1)
Number of subjects: 53
Study 9386710 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopy (VATS)
Number of subjects: 39
Study 9386710 — intervention group
Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 39
Study 7909797 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (240 mg/day)
Number of subjects: 11
Study 7909797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 3226529 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 20 mg
Number of subjects: 0
Study 3226529 — intervention group
Group type: EXPERIMENTAL
Intervention: Secobarbital 100 mg
Number of subjects: 0
Study 3226529 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 20 mg
Number of subjects: 0
Study 3226529 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 0
Study 3226529 — intervention group
Group type: COMPARATOR
Intervention: Diphenhydramine 50 mg
Number of subjects: 0
Study 3226529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3226529 — intervention group
Group type: EXPERIMENTAL
Intervention: Central nervous system depressants (general)
Number of subjects: 0
Study 3226529 — intervention group
Group type: COMPARATOR
Intervention: Visual Analog Mood Scale (VAMS)
Number of subjects: 0
Study 3226529 — intervention group
Group type: COMPARATOR
Intervention: Profile of Mood States (POMS)
Number of subjects: 0
Study 3226529 — intervention group
Group type: COMPARATOR
Intervention: Stroop
Number of subjects: 0
Study 2012448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual captopril (25 mg)
Number of subjects: 20
Study 2012448 — intervention group
Group type: COMPARATOR
Intervention: Sublingual nifedipine (10 mg)
Number of subjects: 20
Study 63749 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 750 mg desferrioxamine before transfusion
Number of subjects: 12
Study 63749 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular injection of 750 mg desferrioxamine after transfusion
Number of subjects: 12
Study 63749 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of 750 mg desferrioxamine over 24 hours
Number of subjects: 12
Study 63749 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of desferrioxamine after transfusion
Number of subjects: 12
Study 63749 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of 1500 mg desferrioxamine over 24 hours
Number of subjects: 12
Study 30763404 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation) over the DLPFC, 1.5 mA for 20 minutes during three consecutive days
Number of subjects: 22
Study 30763404 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (same electrode placement as active stimulation)
Number of subjects: 22
Study 30763404 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation) over the DLPFC
Number of subjects: 22